Long-Term Outcomes Described for Survivors of Childhood ALL

TURSDAY, Jan. 20, 2022 (HealthDay News) -- In an article published online Dec. 29 in Cancers, long-term adverse and positive outcomes are described for survivors of childhood acute lymphoblastic leukemia (ALL).
Charlotte Sleurs, Ph.D., from the University Hospital Leuven in Belgium, and colleagues examined potential risk factors for decreased quality of life and life challenges in long-term childhood ALL survivors enrolled in studies between 1971 and 1998. Self-report questionnaires were obtained from 186 survivors (median time since diagnosis, 20.5 years), including the Short Form Health Survey (SF-12) and Impact of Cancer-Childhood Survivors (IOC-CS).
The researchers observed no association for mental component scores of SF-12 with any risk factor. Relapsed, irradiated, and National Cancer Institute high-risk patients had lower physical component scores. In female, younger (younger than 6 years), and relapsed patients, the life challenges IOC-CS subscale was more negatively impacted by cancer. In relapsed versus nonrelapsed patients, the personal growth subscale was more positively impacted, while body and health and socializing were less positively impacted. In older patients (older than 6 years), socializing was more positively impacted.
"Given that younger, female, and relapsed patients might experience more life challenges up to many years after treatment, psychosocial support focusing on this issue could be recommended," the authors write. "On the other hand, relapse, irradiation, and high-risk categorization might lead to more physical challenges, which should receive specialized physiotherapeutic interventions, including support of a healthier lifestyle."
Related Posts
Daily Baby Aspirin Raises Odds for Brain Bleeds, With No Lowering of Stroke Risk
THURSDAY, July 27, 2023 (HealthDay News) -- For years, older adults took a baby...
Hormonal Therapies Boost Mental Health of Transgender People, and Few Stop Treatment
TUESDAY, June 20, 2023 (HealthDay News) -- In the face of an ongoing and...
Una compañía china podría ayudar a aliviar la escasez de un fármaco para el cáncer en EE. UU.
LUNES, 5 de junio de 2023 (HealthDay News) -- Estados Unidos se enfrenta a un...
Novo Nordisk reducirá los precios de la insulina en hasta un 75 por ciento
MARTES, 14 de marzo de 2023 (HealthDay News) -- Novo Nordisk Inc. se convirtió...